In addition, after collating clinical data from patients in TCGA, it was found that SGOL1 expression level was associated with proliferation of tumor cells and was an independent predictor of poor prognosis in HCC patients, suggesting that SGOL1 is an oncogene in HCC and its overexpression promotes tumor progression. This evidence concerns the gene SGO1 and neoplasm.